Press Releases
Post a press release | Manage press releases
-
Viz.ai™ Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium™
Press release from Viz.ai • November 19, 2022 -
Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
Press release from Viz.ai • November 16, 2022 -
FLEXcon Commercializes First-to-Market Hydrogel-Free Biosensing Electrode Technology: Materials Ready to Differentiate Wearable Device Manufacturers and Improve Patient Experience
Press release from FLEXcon Company • November 10, 2022 -
New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been Referred for Neurovascular Review
Press release from Viz.ai • November 10, 2022 -
Cephasonics Announces New Integrated Application-Ready OEM Ultrasound Cart Systems
Press release from Cephasonics Ultrasound • November 09, 2022 -
Viz.ai Launches AI-Powered Viz Cardio Suite
Press release from Viz.ai • November 04, 2022 -
Vivera Welcomes Saurabh Radhakrishnan to its Advisory Board
Press release from Vivera Pharmaceuticals • November 01, 2022 -
Vivera Enters $6B Market with Speech Assessment and Feedback Device Patent Allowance
Press release from Vivera Pharmaceuticals • October 25, 2022 -
Vivera Welcomes Healthcare Founder and CEO Lea Ramirez to its Advisory Board
Press release from Vivera Pharmaceuticals • October 20, 2022 -
Value of Tissue Analytics for Remote Care Highlighted in Research From Australian Virtual Wound Care Program
Press release from Net Health • October 17, 2022 -
Freudenberg Medical Expands Handle Design Center of Excellence
Press release from Freudenberg Medical • October 13, 2022 -
Vivera Appoints World-Renowned Regulatory Leader Dr. Geetha Rao to Advisory Board
Press release from Vivera Pharmaceuticals • October 12, 2022 -
AVer Receives Frost & Sullivan 2022 Best Practices Award
Press release from AVer Information Inc. • October 11, 2022 -
Vivera Calls for Better Solutions Amidst $1.5 Trillion Opioid Addiction Crisis Economic Burden
Press release from Vivera Pharmaceuticals • October 03, 2022 -
Vivera Files Response Defending Itself Against The SEC’s Recent Threat Of A Civil Suit
Press release from Vivera Pharmaceuticals • September 30, 2022 -
Vivera Receives 3rd Patent for ZICOH, Expanding Into $500B Prescription Market
Press release from Vivera Pharmaceuticals • September 28, 2022 -
BrightInsight Adds Xealth, Woebot Health and Claritas Rx to the BrightInsight Ecosystem
Press release from BrightInsight, Inc. • September 27, 2022 -
Lazurite and Minnetronix Medical Make New Wireless Surgical Camera a Reality
Press release from Minnetronix Medical • September 21, 2022 -
BrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for Diagnostics
Press release from BrightInsight, Inc. • September 21, 2022 -
PharmaVoice names ‘Red Jacket’ honorees at virtual event
Press release from Industry Dive • September 16, 2022
